CUMBERLAND PHARMACEUTICALS REPORTS 17% REVENUE GROWTH FOR FULL YEAR 2022

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to CUMBERLAND PHARMACEUTICALS REPORTS 17% REVENUE GROWTH FOR FULL YEAR 2022

Cumberland Pharmaceuticals (CPIX) Reports Q4 Loss of $0.05/sh

March 7, 2023 4:38 PM EST

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q4 EPS of ($0.05). Revenue for the quarter came in at $9.1 million versus the consensus estimate of $8.07 million.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

... More